Targeted Genetics to Present at Invest Northwest Investor and CEO Forum 2008

SEATTLE, WA -- (MARKET WIRE) -- 03/12/08 -- Targeted Genetics Corporation (NASDAQ: TGEN) announced today that H. Stewart Parker, President and Chief Executive Officer, will present a company overview at the Invest Northwest(TM) Investor and CEO Forum on Tuesday, March 18, at 8:40 a.m. Pacific Time at the Bell Harbor International Conference Center in Seattle, WA.

The presentation will be webcast live and available for replay from the Targeted Genetics website, www.targetedgenetics.com. Links to connect can be found on the Company's homepage under the "Events" section.

About Targeted Genetics

Targeted Genetics Corporation is a biotechnology company committed to the development of innovative targeted molecular therapies for the prevention and treatment of acquired and inherited diseases with significant unmet medical need. Targeted Genetics' proprietary Adeno-Associated Virus (AAV) technology platform allows it to deliver genes that encode proteins to increase gene function or RNAi to decrease or silence gene function. Targeted Genetics' product development efforts target inflammatory arthritis, AIDS prophylaxis, congestive heart failure and Huntington's disease. To learn more about Targeted Genetics, visit Targeted Genetics' website at www.targetedgenetics.com.

Investor and Media Contacts:

Stacie D. Byars WeissComm Partners for Targeted Genetics Corporation 415.946.1072 sdbyars@wcpglobal.com

Carolyn Wang WeissComm Partners 415.946.1065 cbwang@wcpglobal.com

2008-03-12 18:01:34 0311333 MARKETWIRE